MCT Business Scope
The Way-Maker
MCT is a specialized nutraceutical company,focusing on metabolism to analyze the root causes of diseases and
provide cutting-edge solutions.
MCT has created groundbreaking technologies for innovative
solutions within the Metabolism Targeting & Balancing framework.
The precise understanding of the relationship between metabolism and
diseases has enabled the development of 50+ nutraceutical products with proven clinical efficacies.
We have successfully completed Proof of Concept for metabolic disease
treatment through various clinical trials in tens of hospitals and numerous case
studies carried out in over a thousand pharmacies and hundreds of hospitals.
Currently, we are expanding into drug development and functional foods.
Contents MCT provides up-to-date high-quality information through various video content
-
Methylglyoxal Identified as a Cause of Depression and Cognitive Decline – Published Research 2024-12-18
-
MetaCen Therapeutics: "Advanced Glycation End-products, a Major Cause of Skin Aging and Inflammation" 2024-12-18
-
MetaCen Therapeutics Demonstrates Efficacy in Reducing Advanced Glycation End Products (AGEs) 2024-12-10
-
MetaCen Therapeutics Launches ‘Genesis Ace’ 2024-12-10
-
The AGEs Society, Patent for "AGEs Probiotics V3" Gains Attention 2024-12-04
-
Parkinson's Disease, Linked to Glucose Metabolism Dysregulation Caused by Gut Microbiota 2024-12-04
-
Metacen Therapeutics demonstrates the effectiveness of glycotoxin-degrading probiotic strains in alleviating fatty liver, hepatitis, and liver fibrosis 2024-09-26
-
MetaCen Therapeutics: A New Paradigm in Liver Health with ‘Liver Lover (Gan Ae JinShim).’ 2024-09-09
-
The AGEs Society launches ionized calcium product 'Signal Two On.’ 2024-09-09
-
The AGEs Society launches 'Soy Lecithin,' a product containing lecithin. 2024-09-09
